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Mutations in CSTA, Encoding Cystatin A, Underlie
Exfoliative Ichthyosis and Reveal a Role for This
Protease Inhibitor in Cell-Cell Adhesion
Diana C. Blaydon,1 Daniela Nitoiu,1 Katja-Martina Eckl,2 Rita M. Cabral,1 Philip Bland,1
Ingrid Hausser,3 David A. van Heel,1 Shefali Rajpopat,1 Judith Fischer,4,5 Vinzenz Oji,6 Alex Zvulunov,7,8
Heiko Traupe,6 Hans Christian Hennies,2,9,10 and David P. Kelsell1,*
Autosomal-recessive exfoliative ichthyosis presents shortly after birth as dry, scaly skin overmost of the bodywith coarse peeling of non-
erythematous skin on the palms and soles, which is exacerbated by excessive moisture and minor trauma. Using whole-genome homo-
zygosity mapping, candidate-gene analysis and deep sequencing, we have identified loss-of-function mutations in the gene for protease
inhibitor cystatin A (CSTA) as the underlying genetic cause of exfoliative ichthyosis. We found two homozygous mutations, a splice-site
and a nonsense mutation, in two consanguineous families of Bedouin and Turkish origin. Electron microscopy of skin biopsies from
affected individuals revealed that the level of detachment occurs in the basal and lower suprabasal layers. In addition, in vitro modeling
suggests that in the absence of cystatin A protein, there is a cell-cell adhesion defect in human keratinocytes that is particularly prom-
inent when cells are subject to mechanical stress. We show here evidence of a key role for a protease inhibitor in epidermal adhesion
within the lower layers of the human epidermis.Cystatins form a superfamily of protease inhibitors,
which could be further subdivided into three groups on
the basis of their different distributions and molecular
structure.1,2 Cystatin A (also known as stefin A) is a mem-
ber of the type 1 cystatins (comprising stefin A and B)
that have a mainly intracellular localization, although
cystatin A has also been detected in sweat and in the
medium of cultured keratinocytes.3 The cystatins are
tight, reversible inhibitors of the papain-like lysosomal
cysteine proteases, such as cathepsins B, H, and L.4–6
Furthermore, an imbalance of these proteases and their
cystatin inhibitors is found in many cancers and other
diseases.7–9
Cystatin A was originally identified as a component of
the cornified cell envelope in the upper layers of the
skin10 and has also been shown to be a potent inhibitor
of exogenous proteases, such as the dust mite allergens
Der p 1 and Der f 1,3 which can break down the epidermal
barrier of the skin. In addition, cystatin A has been associ-
ated with atopic dermatitis (AD [MIM 603165]),11,12
a chronic inflammatory skin disease often associated with
a defective epidermal barrier.13 We present here a role for
cystatin A in the normal physiology of the skin within
the lower levels of the epidermis and show that loss-of-
function mutations in cystatin A underlie a peeling skin
phenotype in the absence of an obvious epidermal barrier
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family with autosomal-recessive exfoliative ichthyosis
(MIM 607936) presenting in five individuals as circum-
scribed peeling of the skin on palms and soles associated
with dry and scaly skin (Figures 1A and 1B). Initial linkage
analysis with microsatellites showed suggestive linkage to
chromosomal region 12q13.14 In view of the fact that the
unaffected mother was uninformative for all the markers
in this region of the genome, we decided to reassess the
linkage analysis in this family. The study was approved by
the South East National Health Service research ethics
committee and by the institutional review board of the
University Hospital of Mu¨nster, and all patients enrolled
gave their informed consent. High-resolution homozy-
gosity mapping was performed by genotyping two affected
individuals (Figure 1C, individuals IV-10 and V-3) with the
Affymetrix GeneChip Human Mapping 250K Nsp SNP
array (Affymetrix, SantaClara, CA,USA) (see Table S1, avail-
able online). GeneChip DNA Analysis Software (Affyme-
trix, Santa Clara, CA, USA) was used for calling SNP geno-
types and a large block of homozygosity (9333.1 kb),
containing approximately 60 genes and shared by both
affected individuals, was identified on chromosomal region
3q21 between rs6783609 and rs6438966. Using PLINK
to analyze the SNP data,15 we observed no significant
blocks of shared homozygosity on chromosomal region
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Figure 1. Identification of CSTA Mutations
(A) The left foot of an affected individual showing marked hyperkeratosis with an aspect of water-sensitive palmoplantar keratoderma
and superficial exfoliation of skin.
(B) The lower right arm of an affected individual showing slight hyperkeratosis and exfoliation.
(C) Linkage to chromosomal region 3q21 in a large consanguineous Bedouin family with autosomal-recessive exfoliative ichthyosis
confirmed by genotyping microsatellite markers D3S3709, D3S3720, and D3S3645.
(D) Candidate-gene screening in the Bedouin family identified a 30 splice-site variant, c.67-2A>T, in CSTA, a cysteine protease inhibitor
found in the skin (left panel). Affected individuals are homozygous for c.67-2A>T, whereas the unaffected parents are both carriers of
c.67-2A>T; this indicates that the variant segregates with the disease. Analysis of CSTA in a Turkish family with a similar phenotype
identified the homozygous nonsense mutation c.256C>T (right panel).chromosomal regions 4p15 and 5q23 were 1976.4 kb and
1892.8 kb, respectively (see Table S2). The new region of
homozygosity on 3q21 lies between an uninformative
microsatellite marker, D3S2460, and a heterozygousmicro-
satellite marker, D3S1764, used in our previous study.
Linkage to 3q21 was confirmed by genotyping microsatel-
lite markers (D3S3709 [LOD 2.67], D3S3720 [LOD 3.27]
and D3S3645 [LOD 3.13]) across the region (Figure 1C).
CSTA (MIM 184600), located within the block of homozy-
gosity on 3q21, was chosen as a likely candidate gene
because it encodes a protein that is known to be expressed
in keratinocytes.10 We sequenced all three coding exons
and the flanking exon/intron boundaries of CSTA
(NM_005213.3) by using standard Sanger sequencing
methods in all available members of the Bedouin family.
All affected individuals were homozygous for an A>T
change affecting the 30 splice-consensus sequence of intronThe Americ1, c.67-2A>T (p.Val23_Gln26del), whereas theparentswere
heterozygous carriers for c.67-2A>T, and unaffected indi-
viduals were either heterozygous or wild-type (WT)
(Figure 1D). c.67-2A>T was not detected in 300 chromo-
somes fromnormal controls and isnotpresent in thedbSNP
or 1000 Genomes databases.
Because we no longer have access to material from
affected members of the Bedouin family to confirm the
effect of the putative splice-site mutation on the in vivo
processing of CSTA, we included all the exons found in
the block of homozygosity on chromosomal region 3q21
in a next-generation sequencing project to verify that there
were no other potentially disease-causing mutations
within this region in these individuals. All the exons
were captured and sequenced in one affected individual
(V-3 in Figure 1C) from the Bedouin family.16 Briefly, all
the exons located within the region of interest for eachan Journal of Human Genetics 89, 564–571, October 7, 2011 565
disease (i.e., 121,613,170 – 124,440,035 bp on chromo-
somal region 3q21) were extracted from the UCSC
Genome Browser database and probes to all the exons
designed and included on a custom capture microarray
NimbleGen (Roche Nimblegen, Madison, WI, USA). DNA
from the individuals of interest was randomly fragmented
with a Bioruptor sonicator (Diagenode, Denville, NJ, USA)
and the library of adaptor-ligated DNA fragments was
prepared by following the Illumina protocol. The DNA
library was then hybridized to the custom designed micro-
array from NimbleGen for 72 hr, after which time any un-
bound DNA was washed off and the captured DNA was
eluted with sodium hydroxide and amplified in a PCR
with primers against the common adaptor sequences.
The captured, amplified DNA fragments were then
sequenced as paired-end reads on the Illumina GAIIx (Illu-
mina, San Diego, CA, USA). Raw 76 bp paired-end reads
were aligned to the human reference sequence (hg19)
with novoalign, including the soft clipping, adaptor trim-
ming, and base-call quality calibration options. Filtering
for clonal reads, pileup generation, and SNP calling on
the basis of allele counts and read-depth were performed
with custom Perl/Cþþ scripts. We filtered the variants
against dbSNP and 1000 Genomes to identify previously
unreported variants. The 30 splice-site change in CSTA,
c.67-2A>T, was identified by next-generation sequencing.
The only other coding change identified in the region was
a predicted missense change (c.1058A>G, p.Asn224Ser)
in SEMA5B (NM_001031702.2), a gene that encodes
a protein involved in axonal guidance during neural
development and, hence, does not represent an obvious
candidate gene for exfoliative ichthyosis. In parallel, we
identified, by standard Sanger sequencing in a Turkish
familywith a very similar phenotype of exfoliative ichthyo-
sis, a homozygous nonsense mutation in CSTA, c.256C>T
resulting in the premature termination codon p.Gln86stop
(Figure 1D, right panel).We did not have access tomaterials
suitable for testing a potential synthesis of a truncated
protein; however, the altered glutamine residue is highly
conserved (ConSeq17 score 7) and the termination codon
is located within the conserved cystatin domain of cystatin
A, thus clearly indicating that p.Gln86stop is a deleterious
mutation. This finding provides strong support for muta-
tions in CSTA as the underlying cause of exfoliative
ichthyosis.
To assess the potential effect of c.67-2A>T on the
splicing of CSTA, we compared WT and mutated DNA
sequences by using in silico splice-site predictor programs.
The splice-site predictor software Neural Network Splice
Site Prediction Tool18 predicts that the CSTA c.67-2A>T
mutation would abolish the 30 splice-acceptor site (Fig-
ure 2A). Likewise, the online program for scoring 30 splice
sites, MaxEntScan::score3ss,19 predicts a much lowermaxi-
mum entropy score for the mutant splice site (4.89) when
compared to the WT splice site (13.26). To confirm the
impairment of the c.67-2A>T splice site in vitro, we
analyzed expression of minigene constructs in HEK293T566 The American Journal of Human Genetics 89, 564–571, Octobercells. Briefly, two CSTAminigene constructs were prepared
by cloning each of the three CSTA exons, along with
approximately 100 bp of surrounding intron sequence,
into the pcDNA3 vector. The WT minigene construct con-
tained the normal CSTA sequence as found in the human
genome database, whereas the mutant minigene construct
contained the c.67-2A>T splice-site change. Both mini-
gene constructs were transfected into human HEK293T
cells, which do not express CSTA with FuGENE 6 transfec-
tion reagent (Roche Diagnostics, Burgess Hill, West Sussex,
UK). Forty-eight hours after transfection, RNA was col-
lected from the transfected cells with the QIAGEN RNeasy
minikit (QIAGEN, Crawley, West Sussex, UK). cDNA was
made with a mixture of Oligo dT and random hexamer
primers and SuperScript II Reverse Transcriptase (Invitro-
gen, Paisley, UK). The cDNA was then amplified with
a forward primer in exon 1 of CSTA and a reverse primer
in exon 3 of CSTA, and the PCR products were sequenced.
Analysis of splicing of the CSTA minigene construct re-
vealed that the 30 splice-site mutation c.67-2A>T leads to
skipping of the first 12 base pairs of exon 2 of CSTA, which
translates to an in-frame deletion of four amino acid resi-
dues in the cystatin A protein (p.Val23_Gln26del) (Fig-
ure 2B). Immunoblotting of lysates collected from cells
transfected with the minigene constructs showed greatly
reduced levels of protein expression from the mutant
construct (Figure 2C), which we predict to be due to the
utilization of the much weaker splice-acceptor site within
exon 2, as predicted by the Neural Network Splice Site
Prediction Tool (Figure 2A). Furthermore, in silico mod-
eling of the WT and mutated cystatin A proteins revealed
clear structural differences in the mutant cystatin A pro-
tein, including: (1) the division of the first b sheet into
two shorter b sheets, (2) the loss of a complete turn and
change in orientation of the a-helix, and (3) the introduc-
tion of a second twist in the fourth b sheet (Figures 2D and
2E). These changes in the tertiary structure of the mutated
cystatin A protein might alter the relative location of vital
residues involved in the binding of cystatin A to potential
cathepsin substrates6 and, hence, could detrimentally
affect the ability of cystatin A to bind. Therefore, the
splice-site mutation c.67-2A>T in all likelihood represents
a nonfunctional allele and, hence, together with the
finding of nonsense mutations in the Turkish family
reveals that loss-of-function mutations in CSTA underlie
congenital autosomal-recessive exfoliative ichthyosis.
The Turkish and Bedouin families both have a very
similar phenotype that presents shortly after birth as
a dry, scaly skin over most of the body and coarse peeling
of nonerythematous skin on the palms and soles, which is
exacerbated by excessive moisture (aquagenic) and minor
trauma. Electron microscopy of skin biopsies from both
families revealed that the upper layers of the epidermis
appear mostly normal, whereas there is prominent inter-
cellular edema of the basal and suprabasal cell layers and
aggregates of tonofilaments in the basal keratinocytes
(Figure 3A) demonstrating that the skin peeling initiates7, 2011
Figure 2. Evaluation of the c.67-2A>T Mutant Cystatin A
(A)With the Neural Network Splice Site Prediction software18 theWTCSTA splice-site scores amaximum score of 1, whereas themutated
splice site, c.67-2A>T, is predicted to score 0. A predicted alternative splice site that is 12 bp into exon 2 has a very weak score of 0.17.
(B) An in vitro splice assay showed that in the presence of the c.67-2A>Tmutation, the splicing machinery uses an alternative splice site
that leads to skipping of the first 12 bp of exon 2 of CSTA (boxed nucleotides on sequence trace), predicted to result in an in-frame dele-
tion of the four amino acids: Val-Lys-Pro-Gln (residues 23-26) in the cystatin A protein.
(C) Immunoblotting of lysates collected from HEK293T cells transfected with empty pcDNA3 vector, the mutant CSTA minigene
construct with the c.67-2A>Tsplice-site change (Mut), and theWTCSTAminigene construct showed greatly reduced levels of expression
from the mutant construct, probably because of utilization of the much weaker splice-acceptor site within exon 2.
(D) In silico modeling shows the predicted ribbon structure of WT cystatin A.
(E) In silico modeling of the splice-site mutant, c.67-2A>T, cystatin A with the four amino acid deletion; the model shows the possible
structural differences between the mutant and WT proteins: (1) the first b sheet is split by a random coil giving two shorter b sheets, (2)
the a-helix has lost one complete turn and changed its orientation, and (3) the fourth b sheet has a second twist. Structures determined
from amino acid sequence with i-Tasser online server29 and figures produced with Swiss-PdbViewer 4.0.30by weakness in keratinocyte attachment at the basal and
lower suprabasal level in the affected individuals. A
detailed view of the cell-cell contacts showed a loss in
number and tightness of the desmosomes in the basal layer
as compared to the upper epidermal layers and a partial
loosening of their intercellular interaction (Figure 3A). Im-
munostaining of normal skin sections revealed that cysta-
tin A is localized throughout all suprabasal layers of the
epidermis with a diffuse cytoplasmic distribution and the
strongest synthesis in the granular layer (Figure 3B). To
mimic the phenotype observed in these families in an
in vitro model, we have first used ON-TARGETplus SMART-
pool siRNA (Dharmacon, Chicago, IL, USA) to knock downThe Americcystatin A expression in the HaCaT human keratinocyte
cell line and studied the effect of mechanical stress on
these cells. Cells were seeded at 2 3 105 cells/35 mm well
and transfected with 100 nM (final concentration) of
either CSTA siRNA (CSTA KD) or nontargeting pool siRNA
(NTP) (Dharmacon). siRNA was prepared by mixing 10 ml
of 20 mM stock concentration with 190 ml of serum-free
and antibiotic-free Dulbecco’s Modified Eagle’s Medium/
Nutrient F-12 Ham (DMEM-F12) (Sigma-Aldrich) and
transfected with 6 ml DharmaFECT 1 (Dharmacon) diluted
in 194 ml of serum-free and antibiotic-free DMEM-F12
media. Seventy-two hours after transfection, the efficiency
of the knockdownwas analyzed by immunoblotting of cellan Journal of Human Genetics 89, 564–571, October 7, 2011 567
Figure 3. Loss of Cystatin A Protein Affects Cell-Cell Adhesion
(A) Electron microscopy of a skin biopsy of ridged skin from palm and sole, respectively, from an affected member of the Turkish family.
The upper layers of the epidermis appear mostly normal (1), whereas there is prominent intercellular edema of the suprabasal and basal
cell layers (2) and aggregates of tonofilaments in the basal keratinocytes (3, arrow), suggesting that the skin peeling initiates at the basal-
suprabasal level in the affected individuals. In higher magnification, cell-cell adhesion looks normal with a regular structure of desmo-
somes in upper layers (4) but there is loosening of the keratinocyte structure with irregularities in desmosomal interaction in the basal
layer (5, arrow). The following abbreviations are used: SG, stratum granulosum; BL, basal layer.
(B) Staining of normal skin shows that cystatin A is localized throughout the epidermis and has a diffuse cytoplasmic distribution.
(C) The efficiency of cystatin A knockdown (CSTA KD) compared to cells treated with a nontargeting pool (NTP) of siRNA was analyzed
by immunocytochemistry and immunoblotting of cell lysates. An approximately 85% knockdown was achieved.
(D) In an in vitro model of exfoliative ichthyosis, monolayers of CSTA KD cells were stressed mechanically and then stained for keratin
14 (green). Nuclei are stained with DAPI (blue). Upon intense stretching (4 hr) the CSTA KD monolayer broke into many fragments,
whereas the NTP monolayer of cells remained intact (203). At higher magnification (1003), breakage of keratin filaments and widened
intercellular spaces could be seen between theCSTAKD cells, in contrast to no obvious cell-cell adhesion defects in the stretchedNTP cell
monolayer. The scale bar represents 20mm.
(E) A dispase-based dissociation assay was utilized to assess intercellular adhesion by the degree of cell monolayer integrity upon
mechanical stress. CSTA KD cells showed an increased number of monolayer fragments in contrast to the small number of monolayer
fragments observed for the NTP cells. These observations show a statistically significant decrease in cell-cell adhesion in monolayers
lacking cystatin A protein. Error bars show the standard error of the mean.lysates and by immunocytochemistry (Figure 3C). CSTA
KD cells and NTP cells were both seeded on BioFlex
6-well plates coated with pronectin, which contain a flex-
ible, rubber membrane in each 35 mm well (Flexplates,
Flexcell International, Hillsborough, NC, USA), grown to
~80% confluency, and then the monolayers were stressed
mechanically with a Flexcell FX-4000 Tension System
(Flexcell International, Hillsborough, NC, USA)—a
computer-regulated bioreactor that uses vacuum pressure
to apply cyclic or static strain to cells cultured on flex-
ible-bottomed culture plates. Each plate was placed over568 The American Journal of Human Genetics 89, 564–571, Octoberthe loading station containing six planar-faced cylinders
or posts. Each post (25 mm) is centered beneath the rubber
membrane of each 35 mmwell. Cells were subject to cyclic
mechanical stretch with a frequency of 5 Hz (i.e., five
cycles of stretch and relaxation per second) and an elonga-
tion of amplitude ranging from 8% to 14% (i.e., increase in
diameter across the silicone membrane from 8% to
14%). Cells were stretched for 0 hr (unstretched), 1 hr,
and 4 hr, and then fixed and stained for keratin 14
(Figure 3D). Upon intense stretching (4 hr) thickening of
the keratin filaments was observed in both CSTA KD and7, 2011
Figure 4. Organotypic Cultures
(A) Full skin models were generated with NTP and CSTA KD. Loss
of cystatin A was shown by immunoblot analysis in protein
extracts from skin models and by immunostaining against
cystatin A.
(B) Hematoxylin and eosin staining showing completed epidermal
differentiation, hyperkeratosis, and parakeratosis, and a distur-
bance of basal epidermal architecture in CSTA KD organotypic
culture compared to NTP organotypic cultures. The scale bar repre-
sents 50 mm.
(C) Immunostaining against keratin 14 (upper panel) and
E-cadherin (lower panel) demonstrated grossly disorganized struc-
ture, widening of intercellular spaces (arrows), and partial break-
down of keratin intermediate filaments in basal and lower supra-
basal layers of disease models depleted of cystatin A. The scale
bar represents 20 mm. SC is an abbreviation of stratum corneum.
(D) Barrier function appears to be largely maintained in the CSTA
KD organotypic culture in a Lucifer Yellow dye penetration assay
(shown in green) compared to the NTP organotypic culture and
in contrast to the loss of barrier function observed in the corneo-
desmosin knockdown (CDSN KD) organotypic culture, which is
amodel of the generalized peeling skin disease. The scale bar repre-
sents 100 mm.NTP cells; however, the CSTA KDmonolayer had split into
many fragments, whereas the NTP monolayer of cells was
still intact (Figure 3D, 203). At higher magnification,
breakage of keratin filaments and widened intercellular
spaces could be seen in the CSTA KD cells (Figure 3D,
1003); in contrast there are no obvious cell-cell adhesion
defects in the stretched NTP cell monolayer.
In addition, a dispase-based dissociation assay was
utilized to assess intercellular adhesion by the degree of
cell monolayer integrity upon mechanical stress. Cells
were seeded with a density of 2 3 105 cells/35 mm well
and treated, as before, with NTP siRNA or cystatin A siRNA.
Postknockdown, the monolayers were detached by incu-
bating cells with 5 ml/60 mm dish of dispase for 40 min
at 37C. After all monolayers have detached as an intact
sheet, they were subjected to agitation by inversion and
all fragments obtained were counted under a dissection
microscope. CSTA KD cell monolayers showed a high
increase in the number of fragments, demonstrating
a significant decrease in cell-cell adhesion, in contrast to
the very few fragments obtained for the NTP cell mono-
layers (Figure 3E). These data further support the observa-
tions made for the cell stretch assay showing a cell-cell
adhesion defect in cells lacking cystatin A.
To further study the effects of loss of cystatin A on differ-
entiating keratinocytes, we have generated 3D skin models
of exfoliative ichthyosis by knockdown of CSTA in normal
primary keratinocytes, which were then used for organo-
typic tissue culture (Figure 4). 3D models were generated
as described recently.20 In brief, 1 3 105 fibroblasts and
1.0–1.18 3 106 keratinocytes per cm2 were used in a
3 mm tissue-culture insert (BD Biosciences, Heidelberg,
Germany). A mixture of ice-cold bovine collagen I, fibro-
blasts, and serum was poured into each filter insert.
Medium was added after incubation at 37C for 2 hr. Kera-
tinocytes were seeded on the matrix in a total volume of
1 ml KGM per insert. After 24 hr the system was raised to
the air-liquid interface and keratinocyte conditioned
medium was used as differentiation medium for the next
8 days. For model preparation, cells from healthy female
donors aged 46 and 30 years, respectively, and from the
foreskin of a 9-year-old male were used. For preparing
disease models, knockdown in primary keratinocytes was
performed exactly 24 hr before model set up with a set of
three siRNAs (740 pmol each) and 150 ml Lipofectamine
2000 (Invitrogen, Karlsruhe, Germany) in a T225 cell-
culture flask. Full-thickness skin models were cultured
until day 8 at the air-liquid interface. All models used
here were generated from the same sources of cells.
Loss of cystatin A in the 3D models was confirmed by
immunoblot analysis with proteins extracted from model
biopsy specimens and by immunostaining against cystatin
A (Figure 4A). The CSTA KDmodel demonstrated hyperker-
atosis, parakeratosis, and moderate epidermal hyperplasia,
and a disturbance of basal epidermal architecture (Fig-
ure 4B). Epidermal differentiation and basement mem-
brane interaction were confirmed by staining of epidermalThe Americmarker proteins (data not shown). Immunostaining
against keratin 14 and E-cadherin showed a widening of
intercellular spaces and major disorganization of keratino-
cytes in the lower suprabasal and basal layers (Figure 4C).
Circular structures, in contrast to the stretched filaments
in the normal skin models, are indicative of a partial
breakdown of intermediate filaments. To analyze epi-
dermal barrier properties in exfoliative ichthyosis, wean Journal of Human Genetics 89, 564–571, October 7, 2011 569
made use of a Lucifer Yellow penetration assay. A 1 mM
Lucifer Yellow solution (Sigma, Munich, Germany) in
PBS was applied onto control and knockdown skinmodels.
After 1 hr at 37C, the solution was washed off and models
were snap-frozen. Sections were counterstained with
40,6-diamidino-2-phenylindole (DAPI) and visualized with
a fluorescence microscope (LMD6000, Leica, Wetzlar,
Germany). Control full-thickness skin models (WT)
showed an active epidermal barrier. Barrier function, as
assessed by this assay, is largely maintained in the absence
of cystatin A compared with WT organotypic cultures and
in contrast to organotypic cultures grown with corneodes-
mosin (CDSN) KD cells (Figure 4D).
We have identified inactivating mutations in CSTA in
two cases of autosomal-recessive exfoliative ichthyosis.
Our data on the mechanically stressed monolayer of
CSTA KD cells, in combination with the organotypic tissue
culture with CSTA KD keratinocytes and electron micros-
copy of biopsies from affected individuals, reveal an unex-
pected and important role for cystatin A in desmosome-
mediated cell-cell adhesion in the lower levels of the
epidermis. A variant of cystatin A (CSTA, c.287T>C), pre-
dicted to encode a mRNA transcript with reduced stability,
has been associated with AD and is hypothesized to con-
tribute to the defective epidermal barrier seen in AD.12
However, the data from our organotypic 3D culture model
demonstrate that there is no gross barrier defect associated
with CSTA KD, unlike the generalized peeling skin disease
with atopic manifestations, which is caused by mutations
in corneodesmosin and characterized by a severe epi-
dermal barrier defect.21 Accordingly, no atopic component
is observed in the phenotype of individuals with exfolia-
tive ichthyosis. This is also in contrast to Netherton’s
syndrome (MIM 256500), where the loss of a protease
inhibitor, LEKTI, leads to hyperactivity of kallikrein 5
and increased corneodesmosomal degradation, resulting
in ichthyosiform erythroderma and atopic manifesta-
tions.22,23 Similarly, inactivation of the serine protease
matriptase leads to autosomal-recessive ichthyosis accom-
panied by disturbance of the stratum corneum,24,25 but
also a defect in themouse ortholog of thematriptase inhib-
itor, SPINT1, leads to an ichthyosis-like phenotype.26,27 It
should be noted that in a mouse model with a chromo-
somal deletion encompassing Csta, no obvious phenotype
was observed,28 which could reflect differences between
human and mouse skin. In contrast to phenotypes associ-
ated with generalized skin peeling, exfoliative ichthyosis is
caused by lesions in the basal layers of the epidermis char-
acterized by expression of KRT14. This difference might
contribute to the pattern of the phenotype, which is
clearly pronounced on the palmar and plantar skin. As in
other disorders of cornification with a palmoplantar ex-
pression pattern, the defect in the basal and lower supra-
basal layers might thus be particularly susceptible to
mechanical stress, which is strongly present on palmo-
plantar skin. In summary, our data describe mutations in
CSTA associated with a monogenic skin disease and reveals570 The American Journal of Human Genetics 89, 564–571, Octobera previously unknown key role for cystatin A in basal to
suprabasal keratinocyte adhesion.Supplemental Data
Supplemental Data include two tables and can be found with this
article online at http://www.cell.com/AJHG/.Acknowledgments
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